# Stabilis Solutions, Inc.: financial statements, quarterly

SLNG · Nasdaq · CIK 1043186 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/slng.md) · [Financials](/companies/slng/financials.md) · [Filings](/companies/slng/filings.md) · [Insiders](/companies/slng/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/slng/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [15.3](/filings/0001437749-24-033685.md) | [18.0 d](/filings/0001437749-25-005086.md) | [19.8](/filings/0001437749-25-015132.md) | [18.6](/filings/0001437749-25-025131.md) | [17.6](/filings/0001437749-25-033395.md) | [17.3 d](/filings/0001437749-26-007090.md) | [17.3](/filings/0001437749-26-015281.md) | [17.3](/filings/0001437749-26-027112.md) | [20.3](/filings/0001437749-25-033395.md) | [13.3 d](/filings/0001437749-26-007090.md) | [10.4](/filings/0001437749-26-015281.md) | [11.9](/filings/0001437749-26-027112.md) |
| Cost of revenue | $m | [12.1](/filings/0001437749-24-033685.md) | [12.0 d](/filings/0001437749-25-005086.md) | [13.5](/filings/0001437749-25-015132.md) | [13.6](/filings/0001437749-25-025131.md) | [12.6](/filings/0001437749-25-033395.md) | [12.4 d](/filings/0001437749-26-007090.md) | [12.8](/filings/0001437749-26-015281.md) | [12.7](/filings/0001437749-26-027112.md) | [14.7](/filings/0001437749-25-033395.md) | [10.0 d](/filings/0001437749-26-007090.md) | [10.0](/filings/0001437749-26-015281.md) | [9.6](/filings/0001437749-26-027112.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [3.0](/filings/0001437749-24-033685.md) | [3.5 d](/filings/0001437749-25-005086.md) | [3.5](/filings/0001437749-25-015132.md) | [3.3](/filings/0001437749-25-025131.md) | [3.0](/filings/0001437749-25-033395.md) | [1.9 d](/filings/0001437749-26-007090.md) | [4.9](/filings/0001437749-26-015281.md) | [3.1](/filings/0001437749-26-027112.md) | [2.8](/filings/0001437749-25-033395.md) | [2.3 d](/filings/0001437749-26-007090.md) | [2.8](/filings/0001437749-26-015281.md) | [2.5](/filings/0001437749-26-027112.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.1](/filings/0001437749-24-033685.md) | [0.0 d](/filings/0001437749-25-005086.md) | [0.1](/filings/0001437749-25-015132.md) | [0.4](/filings/0001437749-25-025131.md) | [(0.1)](/filings/0001437749-25-033395.md) | [0.1 d](/filings/0001437749-26-007090.md) | [(0.1)](/filings/0001437749-26-015281.md) | [0.2](/filings/0001437749-26-027112.md) | [0.0](/filings/0001437749-25-033395.md) | [(0.1) d](/filings/0001437749-26-007090.md) | [0.0](/filings/0001437749-26-015281.md) | [0.1](/filings/0001437749-26-027112.md) |
| Net income | $m | [(0.2)](/filings/0001437749-24-033685.md) | [1.4 d](/filings/0001437749-25-005086.md) | [1.5](/filings/0001437749-25-033395.md) | [0.0](/filings/0001437749-25-033395.md) | [1.0](/filings/0001437749-25-033395.md) | [2.1 d](/filings/0001437749-26-007090.md) | [(1.6)](/filings/0001437749-26-027112.md) | [(0.6)](/filings/0001437749-26-027112.md) | [1.1](/filings/0001437749-25-033395.md) | [(0.3) d](/filings/0001437749-26-007090.md) | [(4.1)](/filings/0001437749-26-027112.md) | [(4.6)](/filings/0001437749-26-027112.md) |
| Diluted EPS | $ per share | [(0.01)](/filings/0001437749-24-033685.md) | not reported | [0.08](/filings/0001437749-25-015132.md) | [0.00](/filings/0001437749-25-025131.md) | [0.05](/filings/0001437749-25-033395.md) | not reported | [(0.09)](/filings/0001437749-25-015132.md) | [(0.03)](/filings/0001437749-25-025131.md) | [0.06](/filings/0001437749-25-033395.md) | not reported | not reported | not reported |
| Basic EPS | $ per share | [(0.01)](/filings/0001437749-24-033685.md) | not reported | [0.08](/filings/0001437749-25-015132.md) | [0.00](/filings/0001437749-25-025131.md) | [0.05](/filings/0001437749-25-033395.md) | not reported | [(0.09)](/filings/0001437749-26-015281.md) | [(0.03)](/filings/0001437749-26-027112.md) | [0.06](/filings/0001437749-25-033395.md) | not reported | [(0.22)](/filings/0001437749-26-015281.md) | [(0.25)](/filings/0001437749-26-027112.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: not reported
- Research and development: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: not reported
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [4.9](/filings/0001437749-23-031026.md) | [5.4](/filings/0001437749-25-005086.md) | [8.3](/filings/0001437749-24-015119.md) | [11.5](/filings/0001437749-24-025209.md) | [12.4](/filings/0001437749-24-033685.md) | [9.0](/filings/0001437749-26-007090.md) | [9.0](/filings/0001437749-26-015281.md) | [12.2](/filings/0001437749-26-027112.md) | [10.3](/filings/0001437749-25-033395.md) | [7.5](/filings/0001437749-26-027112.md) | [3.1](/filings/0001437749-26-015281.md) | [4.5](/filings/0001437749-26-027112.md) |
| Current assets | $m | [14.6](/filings/0001437749-23-031026.md) | [15.0](/filings/0001437749-25-005086.md) | [15.5](/filings/0001437749-24-015119.md) | [18.9](/filings/0001437749-24-025209.md) | [20.4](/filings/0001437749-24-033685.md) | [17.5](/filings/0001437749-26-007090.md) | [15.4](/filings/0001437749-25-015132.md) | [17.8](/filings/0001437749-25-025131.md) | [19.4](/filings/0001437749-25-033395.md) | [12.9](/filings/0001437749-26-027112.md) | [19.6](/filings/0001437749-26-015281.md) | [23.9](/filings/0001437749-26-027112.md) |
| Total assets | $m | [81.1](/filings/0001437749-23-031026.md) | [81.3](/filings/0001437749-25-005086.md) | [80.6](/filings/0001437749-24-015119.md) | [82.6](/filings/0001437749-24-025209.md) | [89.4](/filings/0001437749-24-033685.md) | [85.6](/filings/0001437749-26-007090.md) | [83.1](/filings/0001437749-25-015132.md) | [83.2](/filings/0001437749-25-025131.md) | [87.1](/filings/0001437749-25-033395.md) | [83.1](/filings/0001437749-26-027112.md) | [115](/filings/0001437749-26-015281.md) | [99.4](/filings/0001437749-26-027112.md) |
| Current liabilities | $m | [13.4](/filings/0001437749-23-031026.md) | [11.7](/filings/0001437749-25-005086.md) | [10.0](/filings/0001437749-24-015119.md) | [11.5](/filings/0001437749-24-025209.md) | [16.5](/filings/0001437749-24-033685.md) | [11.6](/filings/0001437749-26-007090.md) | [10.4](/filings/0001437749-25-015132.md) | [11.3](/filings/0001437749-25-025131.md) | [13.6](/filings/0001437749-25-033395.md) | [10.0](/filings/0001437749-26-027112.md) | [21.0](/filings/0001437749-26-015281.md) | [15.0](/filings/0001437749-26-027112.md) |
| Total liabilities | $m | [21.5](/filings/0001437749-23-031026.md) | [19.5](/filings/0001437749-25-005086.md) | [17.5](/filings/0001437749-24-015119.md) | [18.9](/filings/0001437749-24-025209.md) | [24.0](/filings/0001437749-24-033685.md) | [18.6](/filings/0001437749-26-007090.md) | [17.1](/filings/0001437749-25-015132.md) | [17.8](/filings/0001437749-25-025131.md) | [20.4](/filings/0001437749-25-033395.md) | [16.4](/filings/0001437749-26-027112.md) | [52.2](/filings/0001437749-26-015281.md) | [40.9](/filings/0001437749-26-027112.md) |
| Long-term debt | $m | [8.0](/filings/0001437749-23-031026.md) | [7.7](/filings/0001437749-25-005086.md) | [7.4](/filings/0001437749-24-015119.md) | [7.4](/filings/0001437749-24-025209.md) | [7.1](/filings/0001437749-24-033685.md) | [6.8](/filings/0001437749-26-007090.md) | [6.6](/filings/0001437749-25-015132.md) | [6.3](/filings/0001437749-25-025131.md) | [6.0](/filings/0001437749-25-033395.md) | [5.8](/filings/0001437749-26-007090.md) | not reported | not reported |
| Current portion of debt | $m | [2.3](/filings/0001437749-23-031026.md) | [1.7](/filings/0001437749-25-005086.md) | [1.7](/filings/0001437749-24-015119.md) | [1.2](/filings/0001437749-24-025209.md) | [2.2](/filings/0001437749-24-033685.md) | [2.0](/filings/0001437749-26-007090.md) | [1.7](/filings/0001437749-25-015132.md) | [1.3](/filings/0001437749-25-025131.md) | [2.2](/filings/0001437749-25-033395.md) | [1.9](/filings/0001437749-26-007090.md) | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [59.6](/filings/0001437749-24-033685.md) | [61.8](/filings/0001437749-26-007090.md) | [63.2](/filings/0001437749-25-033395.md) | [63.7](/filings/0001437749-25-033395.md) | [65.4](/filings/0001437749-25-033395.md) | [67.0](/filings/0001437749-26-027112.md) | [65.9](/filings/0001437749-26-027112.md) | [65.5](/filings/0001437749-26-027112.md) | [66.7](/filings/0001437749-25-033395.md) | [66.7](/filings/0001437749-26-027112.md) | [63.0](/filings/0001437749-26-027112.md) | [58.4](/filings/0001437749-26-027112.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:DebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1.5 d](/filings/0001437749-24-033685.md) | [1.3 d](/filings/0001437749-25-005086.md) | [3.9](/filings/0001437749-25-015132.md) | [5.0 d](/filings/0001437749-25-025131.md) | [2.6 d](/filings/0001437749-25-033395.md) | [2.2 d](/filings/0001437749-26-007090.md) | [1.0](/filings/0001437749-26-015281.md) | [4.5 d](/filings/0001437749-26-027112.md) | [2.4 d](/filings/0001437749-25-033395.md) | [0.7 d](/filings/0001437749-26-007090.md) | [12.4](/filings/0001437749-26-015281.md) | [7.1 d](/filings/0001437749-26-027112.md) |
| Capital expenditure | $m | [3.8 d](/filings/0001437749-24-033685.md) | [1.3 d](/filings/0001437749-25-005086.md) | [0.9](/filings/0001437749-25-015132.md) | [1.4 d](/filings/0001437749-25-025131.md) | [1.3 d](/filings/0001437749-25-033395.md) | [5.6 d](/filings/0001437749-26-007090.md) | [0.5](/filings/0001437749-26-015281.md) | [0.6 d](/filings/0001437749-26-027112.md) | [3.9 d](/filings/0001437749-25-033395.md) | [3.1 d](/filings/0001437749-26-007090.md) | [5.3](/filings/0001437749-26-015281.md) | [2.3 d](/filings/0001437749-26-027112.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2022 (2022-03-31) | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [18.2](/filings/0001628280-23-017287.md) | [18.3](/filings/0001437749-23-022839.md) | [18.6](/filings/0001437749-23-031026.md) | [18.5](/filings/0001437749-24-015119.md) | [18.5](/filings/0001437749-24-025209.md) | [18.5](/filings/0001437749-24-033685.md) | [18.6](/filings/0001437749-25-015132.md) | [18.6](/filings/0001437749-25-025131.md) | [18.6](/filings/0001437749-25-033395.md) | [18.6](/filings/0001437749-25-015132.md) | [18.6](/filings/0001437749-25-025131.md) | [18.6](/filings/0001437749-25-033395.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 18,596,301 at 2026-08-07, from the cover of the [10-Q filed 2026-08-12](/filings/0001437749-26-027112.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.